M. Koskas

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
M Koskas, M R Koskas, M. Koskas, Martin Koskas
Publication record
159 papers · 2,977 citations · H-index 30

PAPERS

Diagnostic laparoscopy and cytoreduction surgery in ovarian cancer FIGO III-IV: The impact on survival of one-stage versus two-stage sequence.
20250 citationsauthor #16
Impact of sentinel lymph node mapping on survival in patients with high‐risk endometrial cancer in the early stage: A matched cohort study
20247 citationsauthor #6
Operative Hysteroscopy vs Vacuum Aspiration for Incomplete Spontaneous Abortion: A Randomized Clinical Trial.
202316 citationsauthor #3
DeepCTG® 1.0: an interpretable model to detect fetal hypoxia from cardiotocography data during labor and delivery
202322 citationsauthor #5
A Suggested Modification to FIGO Stage IV Epithelial Ovarian Cancer
20234 citationsauthor #16
Endometrial cancer of the very elderly: Management and survival in the Francogyn population.
20231 citationsauthor #15
Prognostic impact of cytoreductive surgery conducted with primary intent, versus cytoreductive surgery after neoadjuvant chemotherapy, in the management of patients with advanced epithelial ovarian cancers: a multicentre, propensity score‐matched study from the FRANCOGYN group
20236 citationsauthor #16
Brachytherapy and surgery versus surgery alone for IB2 (FIGO 2018) cervical cancers: A FRANCOGYN study.
20232 citationsauthor #20
Impact of severe obesity in the management of patients with high-risk endometrial cancer: a FRANCOGYN study.
20223 citationsauthor #15
Comparison of retroperitoneal and transperitoneal surgical routes in laparoscopic nodal staging for locally advanced cervical cancers (FIGO IB3-IVA).
20220 citationsauthor #19
Breast Reconstruction by Exclusive Lipofilling after Total Mastectomy for Breast Cancer: Description of the Technique and Evaluation of Quality of Life
202222 citationsauthor #6
Less is more in endometrial cancer (SLN, conservative treatment, radical hysterectomy, molecular classification)
20224 citationsauthor #3
2022-RA-1259-ESGO Brachytherapy and surgery versus surgery alone for IB2 (FIGO 2018) cervical cancers: A FRANCOGYN study
20220 citationsauthor #20
Impact of vulvar reconstruction on the accuracy of a nomogram for predicting local recurrence after surgery for vulvar cancer.
20223 citationsauthor #12
Association Between Endometriosis Phenotype and Preterm Birth in France
202214 citationsauthor #8
The amount of preoperative endometrial tissue surface in relation to final endometrial cancer classification.
20224 citationsauthor #10
2022-RA-1099-ESGO Impact of age on surgical resection margins of vulvar squamous cell carcinoma: multicenter descriptive study
20220 citationsauthor #8
[Conservative treatments for endometrial cancer].
20220 citationsauthor #4
Ulipristal Acetate Modifies miRNA Expression in Both Superficial and Basal Layers of the Human Endometrium
20212 citationsauthor #7
[Guidelines for Clinical Practice of the French College of Obstetricians and Gynecologists 2021 : Prophylactic procedures associated with gynecologic surgery].
20214 citationsauthor #16
377 Mini-Invasive (MIS) vs. Open Surgery (OSu): prognostic impact of the surgical approach for endometrial Cancer. A FRANCOGYN collaborative group survey
20211 citationsauthor #15
Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer
20218 citationsauthor #16
994 Impact of lymphadenectomy on survival of patients with serous advanced ovarian cancer after neoadjuvant chemotherapy: a national multicenter study
20210 citationsauthor #6
Status of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group
20219 citationsauthor #6
IVF impact on the risk of recurrence of endometrial adenocarcinoma after fertility-sparing management.
202122 citationsauthor #5
CANCER AFTER NEOADJUVANT CHEMOTHERAPY: A NATIONAL MULTICENTER
20210 citationsauthor #2
[Feasibility and security of laparoscopic (+/- robotic) total hysterectomy in outpatient surgery: a French multicenter retrospective study].
20214 citationsauthor #5
In which cases should endometrial destruction be performed during an operative hysteroscopy? Clinical practice guidelines from the French College of Gynaecologists and Obstetricians (CNGOF).
20215 citationsauthor #6
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer.
202129 citationsauthor #16
Prospective study of fertility‐sparing treatment with chlormadinone acetate for endometrial carcinoma and atypical hyperplasia in young women
20219 citationsauthor #6
Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study
202059 citationsauthor #20
Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
202039 citationsauthor #19
Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN)
202016 citationsauthor #6
Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF☆
202095 citationsauthor #18
Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
202041 citationsauthor #19
The cut-off for estrogen and progesterone receptor in endometrial cancer revisited: an ENITEC collaboration study.
202030 citationsauthor #16
Prognostic Value and Risk Factors of Peritoneal Carcinomatosis Recurrence for Patients with Endometrial Cancer: A Multicenter Study from the FRANCOGYN Group
20204 citationsauthor #15
A survey of French Gynecologists' knowledge and attitudes toward conservative treatment for fertility preservation in young patients with endometrial cancer.
20201 citationsauthor #3
Ovarian Cancer in the Elderly: Time to Move towards a More Logical Approach to Improve Prognosis—A Study from the FRANCOGYN Group
202024 citationsauthor #20
Management of borderline ovarian tumours during pregnancy: Results of a French multi-centre study.
202014 citationsauthor #19
Borderline Ovarian Tumors: French Guidelines from the CNGOF. Part 1. Epidemiology, Biopathology, Imaging and Biomarkers.
202022 citationsauthor #19
[Borderline Ovarian Tumours: CNGOF Guidelines for clinical practice -Diagnosis and management of recurrent borderline ovarian tumors].
20207 citationsauthor #9
Impact of Sociodemographic Characteristics on the Quality of Care in the Surgical Management of Endometrial Cancer: An Analysis of a National Database in the United States
202010 citationsauthor #4
Impact of Extent of Lymphadenectomy on Survival in Patients With Endometrial Cancer: A Matched Cohort Study
20203 citationsauthor #3
[Borderline Ovarian Tumours : CNGOF Guidelines for clinical practice-Epidemiology and risk factors of relapse, follow up and interest of a completion surgery].
202010 citationsauthor #8
Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: an ENITEC collaboration study
20201 citationsauthor #13
[Borderline ovarian tumours: CNGOF Guidelines for clinical practice-Short text].
20203 citationsauthor #19
Management and Survival of Elderly and Very Elderly Patients with Ovarian Cancer: An Age-Stratified Study of 1123 Women from the FRANCOGYN Group
202020 citationsauthor #21
Ulipristal acetate use in adenomyosis: a randomized controlled trial.
202026 citationsauthor #4
A Framework Proposal for Quality and Safety Measurement in Gynecologic Emergency Care
20209 citationsauthor #14
Lymph node metastasis probability in young patients eligible for conservative management of endometrial cancer.
202015 citationsauthor #3
Preoperative endometrial cancer risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: an ENITEC development and external validation study
20200 citationsauthor #20
Saved by the evidence: Hyperthermic intraperitoneal chemotherapy still has a role to play in ovarian cancer.
20196 citationsauthor #11
Gastric cancer during pregnancy: A report on 13 cases and review of the literature with focus on chemotherapy during pregnancy
201924 citationsauthor #7
P80 Impact of extent of lymphadenectomy on survival in patients with endometrial cancer: a matched cohort
20190 citationsauthor #3
A systematic review and meta‐analysis of prognostic factors for remission in fertility‐sparing management of endometrial atypical hyperplasia and adenocarcinoma
201956 citationsauthor #4
Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
20193 citationsauthor #18
Surgical Principles of Endometrial Cancer
20190 citationsauthor #2
Poor outcome in hypoxic endometrial carcinoma is related to vascular density
201912 citationsauthor #19
Development and validation of an endometrial carcinoma preoperative bayesian network using molecular and clinical biomarkers (ENDORISK): an ENITEC collaboration study
20192 citationsauthor #17
Abstract 4879: Poor outcome in hypoxic endometrial carcinoma is related to vascular density
20191 citationsauthor #21
P68 Diagnostic accuracy of endometrial biopsy in endometrial carcinoma grading, correlated to the amount of tissue
20190 citationsauthor #16
1953 Ulipristal Acetate for Adenomyosis: A Multicenter Randomized Trial
20190 citationsauthor #4
EP1200 Impact of socio-demographic characteristics on the quality of care in endometrial cancer: an analysis of a national database in the United States
20190 citationsauthor #4
Absence of predictable long-term molecular effect of ulipristal acetate (UPA) on the endometrium.
20198 citationsauthor #7
Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: an ENITEC collaboration study.
20196 citationsauthor #17
Ovarian protection and fertility preservation in women with cancer: a French national registry analysis between 2005 and 2014.
20199 citationsauthor #3
Lymphadenectomy in elderly patients with high-intermediate-risk, high-risk or advanced endometrial cancer: Time to move from personalized cancer medicine to personalized patient medicine!
201910 citationsauthor #14
Impact of neoadjuvant chemotherapy cycles on survival of patients with advanced ovarian cancer: A French national multicenter study (FRANCOGYN).
201919 citationsauthor #8
Cancer of the corpus uteri
2018251 citationsauthor #3
Prevention of shoulder dystocia: A randomized controlled trial to evaluate an obstetric maneuver.
201810 citationsauthor #9
Adherence to Guidelines During Follow-up of Endometrial Cancer: Analysis of French Health Insurance Database.
20186 citationsauthor #3
Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study
201854 citationsauthor #17
Real-world data of 197 patients treated with ulipristal acetate for uterine fibroids: PREMYA study French population main outcomes.
20173 citationsauthor #3
Magnetic Resonance Imaging Compared with Rectal Endoscopic Sonography for the Prediction of Infiltration Depth in Colorectal Endometriosis.
201717 citationsauthor #10
Evaluation and Selection of Quality Indicators for the Management of Endometrial Cancer
20176 citationsauthor #16
A Real-Life Analysis of Reproductive Outcome after Fertility Preservation in Female Cancer Patients
201714 citationsauthor #2
L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
2016101 citationsauthor #17
Evaluation of models to predict lymph node metastasis in endometrial cancer: A multicentre study.
201633 citationsauthor #1
Long-term oncological safety of minimally invasive surgery in high-risk endometrial cancer.
201640 citationsauthor #1
Abstract OT2-04-01: Optisoins01: Optimizing the patient-breast cancer care pathway; An observational multicentric prospective study
20161 citationsauthor #13
Impact of Radical Hysterectomy on Survival in Patients with Stage 2 Type1 Endometrial Carcinoma: A Matched Cohort Study
201619 citationsauthor #2
Genomic Characterisation and Response to Trastuzumab and Paclitaxel in Advanced or Recurrent HER2-positive Endometrial Carcinoma.
20169 citationsauthor #1
External validation of non-imaging models for predicting distant metastasis in patients with endometrial cancer.
20164 citationsauthor #1
Characteristics and prognosis of patients with early-stage endometrial cancer who refuse adjuvant radiotherapy.
20168 citationsauthor #1
Impact of Conservative Managements in Young Women With Grade 2 or 3 Endometrial Adenocarcinoma Confined to the Endometrium
201625 citationsauthor #3
[Inter-observer variability of decision concerning the route of delivery in case of one previous cesarean section and abnormal pelvic measures].
20163 citationsauthor #4
Therapeutic management of uterine fibroid tumors.
201610 citationsauthor #4
The patient-breast cancer care pathway: how could it be optimized?
201527 citationsauthor #11
Distinction between intrinsic and extrinsic urinary tract endometriosis with MR imaging: the end of the tunnel?
20150 citationsauthor #1
Impact of surgical case volume on the accuracy of preoperative staging and compliance with the guidelines for the management of endometrial cancer.
20151 citationsauthor #1
Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence
201531 citationsauthor #3
Operative hysteroscopy versus vacuum aspiration for incomplete spontaneous abortion (HY-PER): study protocol for a randomized controlled trial
201511 citationsauthor #2
Ulipristal acetate for uterine fibroid-related symptoms.
20159 citationsauthor #3
Hysteroscopic resection in the management of early-stage endometrial cancer: report of 2 cases and review of the literature.
20155 citationsauthor #5
Cancer Incidence in Patients with Atypical Endometrial Hyperplasia Managed by Primary Hysterectomy or Fertility-sparing Treatment.
201516 citationsauthor #8
Staging for endometrial cancer: The controversy around lymphadenectomy - Can this be resolved?
201542 citationsauthor #1
Direct Comparison of Logistic Regression and Recursive Partitioning to Predict Lymph Node Metastasis in Endometrial Cancer
20157 citationsauthor #1
Management of Stage I Endometrial Cancer in France: A Survey on Current Practice
20158 citationsauthor #5
[Extended endometrial ablation risks in the fertility sparing management of adenocarcinoma and atypical hyperplasia of the endometrium].
20156 citationsauthor #3

TIMELINE

1955 0 citations

1960 0 citations

2006 1 citations

2007 0 citations

2008 6 citations

2009 52 citations

2010 244 citations

2011 164 citations

2012 392 citations

2013 130 citations

2014 410 citations

2015 163 citations

2016 253 citations

2017 40 citations

2018 321 citations

2019 156 citations

2020 449 citations

2021 93 citations

2022 50 citations

2023 51 citations

2024 7 citations

2025 0 citations

M. Koskas

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT